Welcome to Geneus Health and Understanding More About You!

Geneus Health is the world’s leading Genetic Addiction testing company. Backed by nearly 30 years of research from our co-founder Dr. Kenneth Blum, Geneus Health has created the Genetic Addiction Risk Score (GARS™) Test to help people better understand their genetic predisposition toward addictive behavior.

“Addictive behavior” encompasses a host of harmful or challenging behaviors, termed “Reward Deficiency Syndrome" (RDS). Your GARS™ Test results are a tool designed to help you identify any potential genetic predisposition to RDS. 

Precision Addiction Management™

Geneus Health has taken this industry leading Genetic Addiction science and partnered with restoreGen™ to offer a personalized approach to managing addiction.

restoreGen™ is a patented neuro-nutrient formulation unlike any other product in the recovery market. It works as a pro-dopamine regulator that decreases addictive behavior cravings.  

For the first time ever, the GARS™ Test can unlock the genetic information of a person’s predisposition to addictive behaviors, and pair those results with 1 of 6 customized restoreGen™ formulations to offer Precision Addiction Management™ (PAM).
The economic cost of the opioid epidemic was about $504 billion in 2015, which is more than six times higher than other studies from previous years, according to a newly released analysis from the White House...Read More


Geneus Health Finalizes Strategic Partnership
Geneus Health and restoreGen™ form partnership to offer Precision Addiction Management™ (PAM)...Read More


Geneus Health Lab


Geneus Health uses cutting edge technology to genotype your DNA with the MassARRAY® System by Agena Bioscience.

When performing the GARS™ Test, your DNA will be analyzed in our state of the art CLIA and CAP certified laboratory.

The Centers for Medicare & Medicaid Services (CMS) regulates laboratory testing in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The objective of the CLIA program is to ensure quality laboratory testing.

The College of American Pathologists (CAP), the leading organization of board-certified pathologists, serves patients, pathologists, and the public by advocating excellence in the practice of pathology and laboratory testing.

These strict regulations ensures the accuracy and reliability of test results.



Testing Process

Getting The Test Done 
Couldn't Be Easier




The GARS™ Test is performed from a simple non-invasive buccal swab specimen.  

All your do is swab the inside of your cheeks and gums and mail it back to our lab in the same kit it came in, along with our prepaid postage and shipping container.

We then unlock your genetics and bring the information to you!

All reporting is provide through secure and confidential handling.

Quick Facts
  • Only 1 out of 10 people addicted to Opioids get treatment for addiction
  • In 2009 the average cost of care per Opioid overdose admission into the ICU was $58,500
  • In 2015 the average cost of care per Opioid overdose admission into the ICU increased to $92,400
  • The number of ICU admissions increased 34% over this seven-year period
  • Of the more than 4 million patients who required intensive care, about 21,700 patients were admitted due to Opioid overdoses.
Source: 162 academic hospitals included in the study, which was led by Beth Israel Deaconess Medical Center in Boston
Share by: